Oncovin Safety Questions, Oncovin Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Oncovin side effects. Check out Health Surveys and Health Polls. If you have questions about Oncovin, you can post them to our Doctors or Ask Patient Community about Oncovin.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Oncovin
Oncovin Safety Reports
Total Oncovin reports: 3.Oncovin FDA safety alerts: No.
Reported hospitalizations: 2.
Take Oncovin Side Effects Survey or Share Your Oncovin Story.
Reported Oncovin Side Effects: hyponatraemia, blood fibrinogen decreased, pancytopenia.
More About Oncovin.
Oncovin Side Effects Report #5198054-0
Consumer or non-health professional from JAPAN reported ONCOVIN problem on Dec 22, 2006. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with ONCOVIN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, hyponatraemia. ONCOVIN dosage: unknown. During the same period patient was treated with GLEEVEC. Patient recovered.
Oncovin Side Effects Report #5225278-6
ONCOVIN problem was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2007. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with ONCOVIN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, hyponatraemia, pancytopenia. ONCOVIN dosage: unknown. During the same period patient was treated with GLEEVEC. Patient was hospitalized. Patient recovered.
Oncovin Side Effects Report #5417778-0
Consumer or non-health professional from JAPAN reported ONCOVIN problem on Aug 10, 2007. Female patient, 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with ONCOVIN. After drug was administered, patient experienced the following problems/side effects: blood fibrinogen decreased, hyponatraemia, pancytopenia. ONCOVIN dosage: unknown. During the same period patient was treated with GLEEVEC. Patient was hospitalized. Patient recovered.